Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Stopped There are no patients enrolled on this study and all efforts are being discontinued.

Conditions

• Recurrent Plasma Cell Myeloma

Interventions

• BIOLOGICAL: Daratumumab
• DRUG: Dexamethasone
• DRUG: Pomalidomide

Sponsor

Academic and Community Cancer Research United

Collaborators

• [object Object]
• [object Object]